BioLight Israeli Life Sciences Investments Ltd.
Period Ending Dec 31, 2013 Dec 31, 2012 Jan 01, 2012 Dec 31, 2010
Total Revenue 24 14 13 -
Cost of Revenue 7 - - -
Gross Profit 17 14 13 -
Operating Expenses
Research and Development 5,307 4,354 1,242 1,608
Sales, General and Admin. 2,905 3,391 2,013 1,920
Non-Recurring Items - - - -
Other - - - -
Operating Income (8,194) (7,731) (3,242) (3,527)
Income From Continuing Operations
Add'l Income/Expense Items 144 133 3,510 315
Earnings Before Interest and Tax (8,051) (7,598) 196 (3,213)
Interest Expense 351 89 349 160
Earnings Before Tax (8,402) (7,687) (153) (3,373)
Income Tax - 10 - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - (72) -
Net Income Cont. Operations (8,402) (7,697) (153) (3,373)
Non Recurring Events
Discontinued Operations - (2) (618) (2,416)
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (8,402) (7,699) (771) (5,789)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (8,402) (7,699) (771) (5,789)